Thomas Henkel
Amministratore Delegato presso IMD Natural Solutions GmbH
Posizioni attive di Thomas Henkel
Società | Posizione | Inizio | Fine |
---|---|---|---|
IMD Natural Solutions GmbH
IMD Natural Solutions GmbH Food RetailRetail Trade IMD Natural Solutions GmbH develops preservative agents. Its product, INS Glycolipid, is a natural mushroom extract that is water soluble and can be used for preservation applications. The company was founded in 2012 and is headquartered in Dortmund, Germany. | Amministratore Delegato | - | - |
S Direkt-Marketing GmbH & Co. KG
S Direkt-Marketing GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services Part of Saalesparkasse, S Direkt-Marketing GmbH & Co. KG is a German company that specializes in telephone campaigns for product sales and efficient outbound campaigns for savings banks. The company is based in Halle, Germany. The company also design new platform offers and provide IT infrastructure, design interfaces to cooperation partners and content, and make fintech applications usable for savings banks. The CEOs of the company are Thomas Henkel, Ingo van Uehm. S Direkt-Marketing offers holistic solutions from a single source for savings banks and network partners, including media customer services, innovative added value, and new digital services. The company offers attractive positions for modern challenges. | Amministratore Delegato | - | - |
TARGOS Molecular Pathology GmbH
TARGOS Molecular Pathology GmbH BiotechnologyHealth Technology Part of Discovery Life Sciences LLC, TARGOS Molecular Pathology GmbH is a German company that provides biomarker services. The company is based in Kassel, Germany. The company was founded in 2005 by Reinhard Büttner, Josef Rüschoff, Thomas Henkel. Thomas Henkel has been the CEO since 2005. TARGOS Molecular Pathology was acquired by Discovery Life Sciences LLC on May 18, 2021. | Amministratore Delegato | 01/01/2005 | - |
Fondatore | 01/01/2005 | - |
Storia della carriera di Thomas Henkel
Precedenti posizioni note di Thomas Henkel
Società | Posizione | Inizio | Fine |
---|---|---|---|
InterMed Discovery GmbH
InterMed Discovery GmbH Miscellaneous Commercial ServicesCommercial Services InterMed Discovery is an emerging world class Natural Product lead-discovery company, driving innovation through the generation of novel product candidates for the life science, food and cosmetics industries. Using one of the most powerful validated Natural Product discovery engines, InterMed Discovery generates proprietary product pipelines of early stage pharmaceuticals and functional ingredients and also supports partners in research and lead generation. Biologically characterized product leads are identified using IMD Bioprofiling and NPsilico, which together comprise a proprietary bioinformatics platform drawing on screening results compiled over many years, complemented by primary biological and chemical research on Natural Products. InterMed Discovery adds to this the industry's largest collections of pure compounds, sample fractions and mixtures as its source for potential Natural Product LEADs. The Company is located in Dortmund, Germany and was founded in 2006 as a Management-Buy-Out of the Natural Products Research Unit of BAYER HealthCare AG. This heritage within a major pharmaceutical company means that, although a new company, InterMed Discovery started life with a highly experienced senior staff as well as the unique sample libraries and data bases drawing on over 20 years of Natural Product research. Presently, InterMed Discovery comprises a total staff of 30 with 16 members dedicated to research. The laboratories at the BioTech Center (BMZ) in Dortmund contain libraries of more than 150,000 screening samples, compounds, and production facilities for micro- to multi-gram scales. | Fondatore | 03/12/2009 | 21/08/2012 |
Corporate Officer/Principal | 07/02/2011 | 21/08/2012 | |
Presidente | 01/02/2006 | 07/02/2011 | |
Bayer HealthCare AG
Bayer HealthCare AG Pharmaceuticals: MajorHealth Technology Bayer HealthCare AG provides healthcare, agriculture, plastics and chemical products. It is an independent company comprising five divisions: Animal Health, Consumer Care, Diabetes Care, Diagnostics and Pharmaceuticals. The company covers the fields of animal health, genetically produced medicines, over the counter products, diagnostic products and prescription drugs. The company is headquartered in Leverkusen, Germany. | Corporate Officer/Principal | 01/01/2005 | 01/01/2005 |
BAYER AG | Corporate Officer/Principal | 01/01/2001 | - |
Formazione di Thomas Henkel
University of Gottingen | Doctorate Degree |
Statistiche
Distribuzione geografica
Germania | 8 |
Posizioni
Corporate Officer/Principal | 3 |
Chief Executive Officer | 3 |
Founder | 2 |
Settori
Health Technology | 4 |
Commercial Services | 3 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
BAYER AG | Health Technology |
Aziende private | 5 |
---|---|
InterMed Discovery GmbH
InterMed Discovery GmbH Miscellaneous Commercial ServicesCommercial Services InterMed Discovery is an emerging world class Natural Product lead-discovery company, driving innovation through the generation of novel product candidates for the life science, food and cosmetics industries. Using one of the most powerful validated Natural Product discovery engines, InterMed Discovery generates proprietary product pipelines of early stage pharmaceuticals and functional ingredients and also supports partners in research and lead generation. Biologically characterized product leads are identified using IMD Bioprofiling and NPsilico, which together comprise a proprietary bioinformatics platform drawing on screening results compiled over many years, complemented by primary biological and chemical research on Natural Products. InterMed Discovery adds to this the industry's largest collections of pure compounds, sample fractions and mixtures as its source for potential Natural Product LEADs. The Company is located in Dortmund, Germany and was founded in 2006 as a Management-Buy-Out of the Natural Products Research Unit of BAYER HealthCare AG. This heritage within a major pharmaceutical company means that, although a new company, InterMed Discovery started life with a highly experienced senior staff as well as the unique sample libraries and data bases drawing on over 20 years of Natural Product research. Presently, InterMed Discovery comprises a total staff of 30 with 16 members dedicated to research. The laboratories at the BioTech Center (BMZ) in Dortmund contain libraries of more than 150,000 screening samples, compounds, and production facilities for micro- to multi-gram scales. | Commercial Services |
Bayer HealthCare AG
Bayer HealthCare AG Pharmaceuticals: MajorHealth Technology Bayer HealthCare AG provides healthcare, agriculture, plastics and chemical products. It is an independent company comprising five divisions: Animal Health, Consumer Care, Diabetes Care, Diagnostics and Pharmaceuticals. The company covers the fields of animal health, genetically produced medicines, over the counter products, diagnostic products and prescription drugs. The company is headquartered in Leverkusen, Germany. | Health Technology |
IMD Natural Solutions GmbH
IMD Natural Solutions GmbH Food RetailRetail Trade IMD Natural Solutions GmbH develops preservative agents. Its product, INS Glycolipid, is a natural mushroom extract that is water soluble and can be used for preservation applications. The company was founded in 2012 and is headquartered in Dortmund, Germany. | Retail Trade |
S Direkt-Marketing GmbH & Co. KG
S Direkt-Marketing GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services Part of Saalesparkasse, S Direkt-Marketing GmbH & Co. KG is a German company that specializes in telephone campaigns for product sales and efficient outbound campaigns for savings banks. The company is based in Halle, Germany. The company also design new platform offers and provide IT infrastructure, design interfaces to cooperation partners and content, and make fintech applications usable for savings banks. The CEOs of the company are Thomas Henkel, Ingo van Uehm. S Direkt-Marketing offers holistic solutions from a single source for savings banks and network partners, including media customer services, innovative added value, and new digital services. The company offers attractive positions for modern challenges. | Commercial Services |
TARGOS Molecular Pathology GmbH
TARGOS Molecular Pathology GmbH BiotechnologyHealth Technology Part of Discovery Life Sciences LLC, TARGOS Molecular Pathology GmbH is a German company that provides biomarker services. The company is based in Kassel, Germany. The company was founded in 2005 by Reinhard Büttner, Josef Rüschoff, Thomas Henkel. Thomas Henkel has been the CEO since 2005. TARGOS Molecular Pathology was acquired by Discovery Life Sciences LLC on May 18, 2021. | Health Technology |
- Borsa valori
- Insiders
- Thomas Henkel
- Esperienza